Search Results
Cybin CEO Doug Drysdale, Dr. David Nutt & Dr. John Krystal Discuss the Psychedelic Landscape
Cybin CEO Doug Drysdale & Deepak Chopra Talk about Their Partnership & The Benefits of Psychedelics
Why Is Cybin Investing So Heavily In Developing Novel Psychedelic Molecules? - CEO Doug Drysdale
Psychedelics and Addiction with Professor David Nutt
prof. David Nutt - The psychedelic revolution in neuroscience and psychiatry #MariaMyśli
Cybin Inc. (NEO:CYBN) (NYSE:CYBN) CEO Doug Drysdale - RICH TV LIVE
🧠 Tim speaks to Professor David Nutt about his psilocybin trials, drug reform and his new drink
Five Telling Takeways from Benzinga Psychedelics Capital Conference
David Nutt: John Maddox Prize winner 2013
🧠 Tim speaks to Professor David Nutt about psilocybin trials, his views on drug reform and Sentia
David Nutt on “illegal” drugs and the future of psychiatry
Beyond Innovation S3: John Krystal, Yale University
